Search Results - "van Ommen, C.H."

Intensive peri‐operative use of factor VIII and the Arg593→Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A by ECKHARDT, C.L., MENKE, L.A., VAN OMMEN, C.H., VAN DER LEE, J.H., GESKUS, R.B., KAMPHUISEN, P.W., PETERS, M., FIJNVANDRAAT, K.

“…Background: A severe and challenging complication in the treatment of hemophilia A is the development of inhibiting antibodies (inhibitors) directed towards…”
Get full text

Etiology and treatment of perinatal stroke; a role for prothrombotic coagulation factors? by Cnossen, M.H, van Ommen, C.H, Appel, I.M

“…Summary The detection rate of perinatal stroke is rising due to improved neuroradiological imaging techniques, increased survival of neonates with severe…”
Get full text

PP320 CATHETER-INFECTION AND -THROMBOSIS IN CHILDREN WITH LONG-TERM HOME TOTAL PARENTERAL NUTRITION by Vegting, I.L, Tabbers, M.M, van Ommen, C.H

Get full text

Mo1900 THE INCIDENCE AND CHARACTERISTICS OF VENOUS THROMBOEMBOLISMS IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE by Aardoom, Martine, Kemos, Polychronis, Ruemmele, Frank, van Ommen, C.H. (Heleen), Croft, Nicholas M., de Ridder, Lissy

Get full text

730 INCREASED RISK OF VENOUS THROMBOEMBOLISM IN PAEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE - A STUDY OF THE INTERNATIONAL PROSPECTIVE SAFETY REGISTRY by Klomberg, Renz, Aardoom, Martine, Kemos, Polychronis, Ruemmele, Frank, Van Ommen, C.H. (Heleen), Croft, Nicholas M., De Ridder, Lissy

Get full text

Recommendations for standardized risk factor definitions in pediatric hospital‐acquired venous thromboembolism to inform future prevention trials: communication from the SSC of the ISTH by Branchford, B. R., Mahajerin, A., Raffini, L., Chalmers, E., Ommen, C. H., Chan, A. K. C., Goldenberg, N. A.

Get full text

Results of a multinational survey of diagnostic and management practices of thromboembolic pulmonary embolism in children by Rajpurkar, M., Williams, S., Goldenberg, N.A., Van Ommen, C.H., Chan, A.K.C., Thomas, R., Biss, T.

“…The incidence of thromboembolic (TE)-pediatric pulmonary embolism (PPE) is increasing. We sought to evaluate current practice patterns and gaps in the…”
Get full text

Recommendations for future research in relation to pediatric pulmonary embolism: communication from the SSC of the ISTH by Biss, T. T., Rajpurkar, M., Williams, S., van Ommen, C. H., Chan, A. K. C., Goldenberg, N. A.

Get full text

The identification of at‐risk patients and prevention of venous thromboembolism in pediatric cancer: guidance from the SSC of the ISTH by Tullius, B. P., Athale, U., Ommen, C. H., Chan, A. K. C., Palumbo, J. S., Balagtas, J. M. S.

Get full text

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study by Maagdenberg, H., Bierings, M. B., Ommen, C. H., Meer, F. J. M., Appel, I. M., Tamminga, R. Y. J., Cessie, S., Swen, J. J., Straaten, T., Boer, A., Maitland‐van der Zee, A. H.

“…Essentials A pediatric pharmacogenetic dosing algorithm for acenocoumarol has not yet been developed. We conducted a multicenter retrospective follow‐up study…”
Get full text

Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort by Maagdenberg, H., Bierings, M. B., van Ommen, C. H., van der Meer, F. J. M., Appel, I. M., Tamminga, R. Y. J., de Boer, A., Maitland‐van der Zee, A. H.

“…Essentials The knowledge of quality and safety of acenocoumarol and phenprocoumon use in children is limited. We used data from a multicenter retrospective…”
Get full text

The upper extremity postthrombotic syndrome score: an international Delphi consensus study to determine the score’s functional disability component by Schropp, Ludo, Cats, Roos B., de Kleijn, Robert J.C.M.F., van Hattum, Eline S., Middeldorp, Saskia, Nijkeuter, Mathilde, Westerink, Jan, Petri, Bart-Jeroen, de Borst, Gert J., Schropp, L., Cats, R.B., de Kleijn, R.J.C.M.F., Black, S., Garcia, D., Meijer, K., Nijziel, M.R., Klappe, E.M., Geroulakos, G., van Ommen, C.H., van Rijn, M.J.E., Freischlag, J., Kruip, M.J.H.A., Huisman, M.V., Coppens, M., Teijink, J.A.W., Kakkos, S.K., Le Gal, G., Westerweel, P.E., Avila, M.L., Kreuziger, L. Baumann, Cate-Hoek, A.J. Ten, Lee, A.Y.Y., Koelemay, M.J., Srivastava, A., Hovens, M.M.C., Ünlü, Ç., Klok, F.A., Douketis, J., Stansby, G., Illig, K.A., Thompson, R.W., Bax, W.A., Poli, D., Kahn, S.R., van Hattum, E.S., Middeldorp, S., Nijkeuter, M., Westerink, J., Petri, B.J., de Borst, G.J.

“…In upper extremity thrombosis research, the occurrence of upper extremity postthrombotic syndrome (UE-PTS) is commonly used as the main outcome parameter…”
Get full text

Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome by Van Ommen, C. H., Heijboer, H., Van Den Dool, E. J., Hutten, B. A., Peters, M.

“…To learn more about the frequencies of congenital prothrombotic disorders in pediatric venous thromboembolism (VTE) and the outcome of this disease, we…”
Get full text

Accrual in supportive care trials in pediatric oncology, a challenge by Schoot, R. A., van Ommen, C. H., Caron, H. N., Tissing, W. J. E., van de Wetering, M. D.

“…Purpose Treatment protocols in pediatric oncology have historically known high accrual rates, up to 94 %. Accrual for supportive care studies on the other hand…”
Get full text